<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>SSCA_B</title>
    <meta name="title" content="NHANES 2001-2002: Cancer antigen CA125 and CA15.3 - Serum (Surplus) Data Documentation, Codebook, and Frequencies" />
    <style type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					padding: 0 3em 1em;
					text-align: left;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					padding: 0 3em 1em;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					.nhanes-doc li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td p {
					margin: inherit;
					padding: 0;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#References li {
					word-wrap: break-word;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</style>
    <style type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</style>
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#SSCA125">SSCA125 - Cancer antigen 125 (U/mL)</a>
              </li>
              <li>
                <a href="#SSCA153">SSCA153 - Cancer antigen 15.3 (mU/mL)</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2001-2002 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Cancer antigen CA125 and CA15.3 - Serum (Surplus) (SSCA_B)</h3>
        <h4> Data File: SSCA_B.xpt</h4>
        <h5 class="left">First Published: June 2019</h5>
        <h5 class="right">Last Revised: August 2022</h5>
        <div style="width: 75%; margin-left: 20%">
          <h5 class="specialnote">Note: The NHANES Biospecimen Program processes were reevaluated in 2021 and 2022 to monitor quality control after a procedural error was identified. This error did not pose any risk of participant disclosure. Addressing this error resulted in the removal of some records from various stored biospecimen data files between 1999 and 2018 that did not meet program standards. After a comprehensive review of all stored specimen datasets, this data file was modified to remove records (5-<10% of records) that were initially included in error. No data values were altered. The sample weights and overall estimates were compared between the original and revised files. The sample weights provided with the original data release are appropriate to use with this updated data file; therefore, no new survey weights were created. The overall estimates from these files were examined and are consistent with the previous file. However, not all possible analyses were performed.</h5>
        </div>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p>Sera from residual
specimens from NHANES 2001-2002 participants were tested for levels of cancer
antigen 125 (CA125) and cancer antigen 15.3 (CA15.3). The results for CA125 in
this data release are reported as U/mL. The results for CA15.3 are reported as
mU/mL. </p><h2 id="Eligible_Sample">Eligible Sample</h2><p>Female participants
age 20+ who consented to storing their samples for future research and had
stored samples from 2001-2002. </p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p>All measurements were performed in the Genital Tract Biology
Laboratory (Brigham and Women&rsquo;s Hospital, Lab Director) following pre-analytic,
analytic, and post-analytic standardized operational procedures (SOPs)
established under the Laboratory director and special chemistry accreditation
by the College of American Pathologists. The lab used the Meso Scale Discovery
(MSD) (Gaithersburg, MD) electrochemiluminescence immunoassay platform. Quality
control (QC) pools were prepared and split into multiple aliquots. To establish
inter-and intra-plate variability, one aliquot of this pool was repeatedly tested
on each assay plate. A coefficient of variation of &lt; 25% was set as a
threshold for acceptance of the data.</p>
<p>In further detail, the following assays and methodology were
applied:</p>
<p><span style="text-decoration: underline;">Human CA125 (single spot, catalog number K151WC) </span></p>
<p>The linearity range for the CA125 was 10,000&ndash;0.6 U/ml
(low limit of detection (LLD) 0.286 U/ml). All samples were tested undiluted and
four samples were repeatedly tested to verify their top or bottom outlier
values. The QC pool for this assay was prepared by pooling a small volume (5
ul/ sample) from over 2000 serum samples which had shown well measurable levels
of CA125 in a prior study using the MSD platform.</p>
<p><span style="text-decoration: underline;">Human Prototype CA15.3 (single spot catalog number
N45ZA-1) </span></p>
<p>The linearity range for the CA15.3 assay was 12,500&ndash;0.76
mU/mL (LLD=0.483 mU/ml). </p>
<p>All samples were tested at 25- or 50-fold dilution and
retested at 250-fold dilution if the first dilution resulted in values above
the linearity of the assay. The QC pool for this assay was prepared by pooling
1.5 ml per sample from seven samples from a pilot study previously tested on
the same assay and found to have high levels. All samples were tested at a
25-fold dilution chosen after multiple dilutions were screened to fit the assay
linearity range, and to correspond to the lowest dilution of the study samples.
Two CA15.3 assay plates were re-tested due to QC failure in the first run.</p>
<p>The unblinded quality control sample pool repeatedly
tested on every assay plate showed the following inter-plate CV and min&ndash;max range
(mean) of intraplate CV of the three QC dilutions tested: (i) CA125, 13% inter-plate
CV and 0.5%&ndash;22% (7%) intraplate CV; (ii) CA15.3: 19% inter-plate CV and 0%&ndash;17%
(4%) intraplate CV. </p><h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p>The acceptable QC pool variation was set to 25%. Back fit analysis of each
calibrator was also set to 25% acceptable level.&nbsp; Outliers were confirmed by repeated testing and
samples outside the linearity range of each assay were repeatedly tested at
adjusted dilution to produce acceptable value.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p>Data was compiled into
a database after all the assays were completed and passed quality control
criteria. The data were not edited.</p>
<p>Data Access: All
data will be made publicly available.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p>Results were
measured as U/mL for CA125 and mU/mL for CA15.3</p>
<p>Exam sample weights should be used for analyses. Please refer to the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx"> Analytic Guidelines </a>and the on-line NHANES <a href="https://www.cdc.gov/nchs/tutorials/">Tutorial</a> for further details on the use of sample weights and other analytic issues.</p>
<p class="MsoNormal" style="line-height: 15.95pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;">&nbsp;</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Cramer DW, Vitonis AF, Pinheiro SP, McKolanis JR, Fichorova RN, Brown KE, et al. Mumps
and ovarian cancer: modern interpretation of an historic association. Cancer
Causes Control. 2010;21(8):1193-201.</li>
          <li>Fortner
RT, Schock H, Le Cornet C, Husing A, Vitonis AF, Johnson TS, et al. Ovarian
cancer early detection by circulating CA125 in the context of anti-CA125
autoantibody levels: Results from the EPIC cohort. Int J Cancer.
2018;142(7):1355-60.</li>
          <li>Terry
KL, Schock H, Fortner RT, Husing A, Fichorova RN, Yamamoto HS, et al. A
Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the
European EPIC Cohort. Clin Cancer Res. 2016;22(18):4664-75.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Females only 20 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="SSCA125">SSCA125 - Cancer antigen 125 (U/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SSCA125</dd>
            <dt>SAS Label: </dt>
            <dd>Cancer antigen 125 (U/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Cancer antigen 125 (U/mL)</dd>
            <dt>Target: </dt>
            <dd> Females only 20 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">0.73 to 569.37</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2391</td>
                <td class="values" align="right">2391</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">2391</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="SSCA153">SSCA153 - Cancer antigen 15.3 (mU/mL)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SSCA153</dd>
            <dt>SAS Label: </dt>
            <dd>Cancer antigen 15.3 (mU/mL)</dd>
            <dt>English Text: </dt>
            <dd class="info">Cancer antigen 15.3 (mU/mL)</dd>
            <dt>Target: </dt>
            <dd> Females only 20 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">95.83 to 704915.87</td>
                <td class="values">Range of Values</td>
                <td class="values" align="right">2391</td>
                <td class="values" align="right">2391</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">2391</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>